Unaudited Forward-Looking Statements Regarding Business Outlook
(In millions, except per share data)

Business Outlook

Three Months Ending

December 31, 2022

GAAP

Measure

Non-GAAP

Adjustments*

Non-GAAP

Measure

Gross margin

60 %

0 %

60 %

Operating expenses

$132

$(23)

$109

Effective tax rate

35 %

(10) %

25 %

Diluted earnings per share - low

$0.35

$0.58

$0.93

Diluted earnings per share - high

$0.45

$0.58

$1.03

* Non-GAAP adjustments include the following estimates: stock compensation expense of $16.9 million, intangible asset
amortization of $6.7 million, and the associated tax impact from the aforementioned items.  

Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)

October 1,

2022

January 1,
2022

Assets

Current assets:

   Cash and cash equivalents

$   483,277

$1,074,623

   Short-term investments

893,131

964,582

   Accounts receivable, net

76,672

98,313

   Inventories

88,447

49,307

   Prepaid expenses and other current assets

84,109

51,748

Total current assets

1,625,636

2,238,573

Property and equipment, net

151,610

146,516

Goodwill

376,389

376,389

Other intangible assets, net

91,650

118,978

Other assets, net

91,012

77,839

Total assets

$2,336,297

$2,958,295

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     81,676

$     47,327

   Current portion of convertible debt, net

--

450,599

   Deferred revenue and returns liability

11,705

13,849

   Other current liabilities

112,320

157,052

Total current liabilities

205,701

668,827

Convertible debt, net

529,062

--

Other non-current liabilities

49,890

77,044

Total liabilities

784,653

745,871

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;

      33,530 and 38,481 shares issued and outstanding at

      October 1, 2022 and January 1, 2022, respectively

3

4

   Retained earnings

1,568,108

2,214,839

   Accumulated other comprehensive loss

(16,467)

(2,419)

Total stockholders' equity

1,551,644

2,212,424

Total liabilities and stockholders' equity

$2,336,297

$2,958,295